genital herpes simplex type 2
Showing 1 - 7 of 7
Genital Herpes Simplex Type 2 Trial (BNT163, Placebo)
Not yet recruiting
- Genital Herpes Simplex Type 2
- BNT163
- Placebo
- (no location specified)
Jun 21, 2022
Genital Herpes Simplex Type 2 Trial in United States (VCL-HB01, VCL-HM01, PBS)
Completed
- Genital Herpes Simplex Type 2
- VCL-HB01
- +2 more
-
Birmingham, Alabama
- +6 more
Feb 25, 2019
Genital Herpes Simplex Type 2 Trial in United States (GEN-003 with Matrix M-2, GEN-003, Placebo)
Completed
- Genital Herpes Simplex Type 2
- GEN-003 with Matrix M-2
- +2 more
-
Birmingham, Alabama
- +6 more
May 30, 2018
Genital Herpes Simplex Type 2 Trial in United States (Matrix-M2, GEN-003, Placebo)
Completed
- Genital Herpes Simplex Type 2
- Matrix-M2
- +2 more
-
Birmingham, Alabama
- +7 more
May 21, 2018
GEN-003-002 Subjects for Efficacy and Immunogenicity
Completed
- Genital Herpes Simplex Type 2
- Observational
-
Birmingham, Alabama
- +12 more
Oct 18, 2017
Genital Herpes Simplex Type 2 Trial in United States (GEN-003 Vaccine (30µg of each antigen), GEN-003 Vaccine (60µg of each
Completed
- Genital Herpes Simplex Type 2
- GEN-003 Vaccine (30μg of each antigen)
- +4 more
-
Birmingham, Alabama
- +15 more
Oct 6, 2017
Genital Herpes Simplex Type 2 Trial in United States (GEN-003 Vaccine (30µg of each antigen), GEN-003 Vaccine (60µg of each
Completed
- Genital Herpes Simplex Type 2
- GEN-003 Vaccine (30μg of each antigen)
- +5 more
-
Birmingham, Alabama
- +15 more
Oct 6, 2017